期刊文献+

Assembly and release of infectious hepatitis C virus involving unusual organization of the secretory pathway

Assembly and release of infectious hepatitis C virus involving unusual organization of the secretory pathway
下载PDF
导出
摘要 AIM: To determine if calnexin(CANX), RAB1 and alphatubulin were involved in the production of hepatitis C virus(HCV) particles by baby hamster kidney-West Nile virus(BHK-WNV) cells. METHODS: Using a si RNA-based approach complemented with immuno-fluorescence confocal microscope and Western blot studies, we examined the roles of CANX, RAB1 and alpha-tubulin in the production of HCV particles by permissive BHK-WNV cells expressing HCV structural proteins or the full-length genome of HCV genotype 1a. Immuno-fluorescence studies in producer cells were performed with monoclonal antibodies against HCV structural proteins, as well as immunoglobulin from the serum of a patient recently cured from an HCV infection of same genotype. The cellular compartment stained by the serum immunoglobulin was also observedin thin section transmission electron microscopy. These findings were compared with the JFH-1 strain/Huh-7.5 cell model.RESULTS: We found that CANX was necessary for the production of HCV particles by BHK-WNV cells. This process involved the recruitment of a subset of HCV proteins, detected by immunoglobulin of an HCV-cured patient, in a compartment of rearranged membranes bypassing the endoplasmic reticulum-Golgi intermediary compartment and surrounded by mitochondria. It also involved the maturation of N-linked glycans on HCV envelope proteins, which was required for assembly and/or secretion of HCV particles. The formation of this specialized compartment required RAB1; upon expression of HCV structural genes, this compartment developed large vesicles with viral particles. RAB1 and alpha-tubulin were required for the release of HCV particles. These cellular factors were also involved in the production of HCVcc in the JFH-1 strain/Huh-7.5 cell system, which involves HCV RNA replication. The secretion of HCV particles by BHK-WNV cells presents similarities with a pathway involving caspase-1; a caspase-1 inhibitor was found to suppress the production of HCV particles from a full-length genome.CONCLUSION: Prior activity of the WNV subgenomic replicon in BHK-21 cells promoted re-wiring of host factors for the assembly and release of infectious HCV in a caspase-1-dependent mechanism. AIM: To determine if calnexin(CANX), RAB1 and alphatubulin were involved in the production of hepatitis C virus(HCV) particles by baby hamster kidney-West Nile virus(BHK-WNV) cells. METHODS: Using a si RNA-based approach complemented with immuno-fluorescence confocal microscope and Western blot studies, we examined the roles of CANX, RAB1 and alpha-tubulin in the production of HCV particles by permissive BHK-WNV cells expressing HCV structural proteins or the full-length genome of HCV genotype 1a. Immuno-fluorescence studies in producer cells were performed with monoclonal antibodies against HCV structural proteins, as well as immunoglobulin from the serum of a patient recently cured from an HCV infection of same genotype. The cellular compartment stained by the serum immunoglobulin was also observedin thin section transmission electron microscopy. These findings were compared with the JFH-1 strain/Huh-7.5 cell model.RESULTS: We found that CANX was necessary for the production of HCV particles by BHK-WNV cells. This process involved the recruitment of a subset of HCV proteins, detected by immunoglobulin of an HCV-cured patient, in a compartment of rearranged membranes bypassing the endoplasmic reticulum-Golgi intermediary compartment and surrounded by mitochondria. It also involved the maturation of N-linked glycans on HCV envelope proteins, which was required for assembly and/or secretion of HCV particles. The formation of this specialized compartment required RAB1; upon expression of HCV structural genes, this compartment developed large vesicles with viral particles. RAB1 and alpha-tubulin were required for the release of HCV particles. These cellular factors were also involved in the production of HCVcc in the JFH-1 strain/Huh-7.5 cell system, which involves HCV RNA replication. The secretion of HCV particles by BHK-WNV cells presents similarities with a pathway involving caspase-1; a caspase-1 inhibitor was found to suppress the production of HCV particles from a full-length genome.CONCLUSION: Prior activity of the WNV subgenomic replicon in BHK-21 cells promoted re-wiring of host factors for the assembly and release of infectious HCV in a caspase-1-dependent mechanism.
出处 《World Journal of Hepatology》 CAS 2016年第19期796-814,共19页 世界肝病学杂志(英文版)(电子版)
基金 Supported by Intramural Program of the National Institutes of Health,National Institute of Allergy and Infectious Diseases(Project No.1 ZIA AI000733-15:Enveloped Virus Glycoprotein/Receptor Interactions)to Edward A Berger,PhD(MSS,LVD,DIR,NIAID) ORISE Senior Fellow award(Award No.1238-1238-03:Department of Energy/Oak Ridge Institute for Science and Education)to Bertrand Saunier,MD,PhD
  • 相关文献

参考文献25

  • 1Daniel P Webster,Paul Klenerman,Geoffrey M Dusheiko.??Hepatitis C(J)The Lancet . 2015 (9973)
  • 2Lyna Zhang,Ajay Yesupriya,Man‐Huei Chang,Eyasu Teshale,Chong‐Gee Teo.??Apolipoprotein E and protection against hepatitis E viral infection in American non‐Hispanic blacks(J)Hepatology . 2015 (5)
  • 3Mercedes Monteleone,Jennifer L. Stow,Kate Schroder.??Mechanisms of unconventional secretion of IL-1 family cytokines(J)Cytokine . 2015 (2)
  • 4Germana Grassi,Giorgia Di Caprio,Gian Maria Fimia,Giuseppe Ippolito,Marco Tripodi,Tonino Alonzi.Hepatitis C virus relies on lipoproteins for its life cycle[J].World Journal of Gastroenterology,2016,22(6):1953-1965. 被引量:3
  • 5Ari Helenius,Markus Aebi.??ROLES OF N-LINKED GLYCANS IN THE ENDOPLASMIC RETICULUM(J)Annual Review of Biochemistry . 2004
  • 6Theodore C. Pierson,Melissa D. Sánchez,Bridget A. Puffer,Asim A. Ahmed,Brian J. Geiss,Laura E. Valentine,Louis A. Altamura,Michael S. Diamond,Robert W. Doms.??A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection(J)Virology . 2005 (1)
  • 7Colin W Shepard,Lyn Finelli,Miriam J Alter.Global epidemiology of hepatitis C virus infection[J].The Lancet Infectious Diseases.2005(9)
  • 8de Jong, Ype P,Rice, Charles M,Ploss, Alexander.??New horizons for studying human hepatotropic infections(J)Journal of Clinical Investigation . 2010 (3)
  • 9MónicaTomás,EmmaMartínez‐Alonso,JoséBallesta,José A.Martínez‐Menárguez.??Regulation of ER–Golgi Intermediate Compartment Tubulation and Mobility by COPI Coats, Motor Proteins and Microtubules(J)Traffic . 2010 (5)
  • 10Jason M. Mackenzie,Alexander A. Khromykh,Robert G. Parton.??Cholesterol Manipulation by West Nile Virus Perturbs the Cellular Immune Response(J)Cell Host & Microbe . 2007 (4)

二级参考文献124

  • 1Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and naturalhistory of HCV infection. Nat Rev Gastroenterol Hepatol 2013; 10:553-562 [PMID: 23817321 DOI: 10.1038/nrgastro.2013.107].
  • 2Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Globalepidemiology of hepatitis C virus infection: new estimates of agespecificantibody to HCV seroprevalence. Hepatology 2013; 57:1333-1342 [PMID: 23172780 DOI: 10.1002/hep.26141].
  • 3Ansaldi F, Orsi A, Sticchi L, Bruzzone B, Icardi G. Hepatitis C virusin the new era: perspectives in epidemiology, prevention, diagnosticsand predictors of response to therapy. World J Gastroenterol 2014;20: 9633-9652 [PMID: 25110404 DOI: 10.3748/wjg.v20.i29.9633].
  • 4Bruggmann P, Berg T, -vrehus AL, Moreno C, Brand-o MelloCE, Roudot-Thoraval F, Marinho RT, Sherman M, Ryder SD,Sperl J, Akarca U, Bal-k I, Bihl F, Bilodeau M, Blasco AJ, Buti M,Calinas F, Calleja JL, Cheinquer H, Christensen PB, Clausen M,Coelho HS, Cornberg M, Cramp ME, Dore GJ, Doss W, DubergAS, El-Sayed MH, Erg-r G, Esmat G, Estes C, Falconer K, Félix J,Ferraz ML, Ferreira PR, Frankova S, García-Samaniego J, GerstoftJ, Giria JA, Gon-ales FL, Gower E, Gschwantler M, Guimar-esPess-a M, Hézode C, Hofer H, Husa P, Idilman R, K-berg M, KaitaKD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W,Lavanchy D, Lázaro P, Marotta P, Mauss S, Mendes Correa MC,Müllhaupt B, Myers RP, Negro F, Nemecek V, -rmeci N, Parkes J,Peltekian KM, Ramji A, Razavi H, Reis N, Roberts SK, RosenbergWM, Sarmento-Castro R, Sarrazin C, Semela D, Shiha GE, SievertW, St-rkel P, Stauber RE, Thompson AJ, Urbanek P, van Thiel I,Van Vlierberghe H, Vandijck D, Vogel W, Waked I, Wedemeyer H,Weis N, Wiegand J, Yosry A, Zekry A, Van Damme P, Aleman S,Hindman SJ. Historical epidemiology of hepatitis C virus (HCV)in selected countries. J Viral Hepat 2014; 21 Suppl 1: 5-33 [PMID:24713004 DOI: 10.1111/jvh.12247].
  • 5European Association for Study of Liver. EASL ClinicalPractice Guidelines: management of hepatitis C virus infection.J Hepatol 2014; 60: 392-420 [PMID: 24331294 DOI: 10.1016/j.jhep.2013.11.003].
  • 6Westbrook RH, Dusheiko G. Natural history of hepatitis C. JHepatol 2014; 61: S58-S68 [PMID: 25443346 DOI: 10.1016/j.jhep.2014.07.012].
  • 7Pawlotsky JM, Flisiak R, Sarin SK, Rasenack J, PiratvisuthT, Chuang WL, Peng CY, Foster GR, Shah S, Wedemeyer H,Hézode C, Zhang W, Wong KA, Li B, Avila C, Naoumov NV.Alisporivir plus ribavirin, interferon free or in combination withpegylated interferon, for hepatitis C virus genotype 2 or 3 infection.Hepatology 2015; 62: 1013-1023 [PMID: 26118427 DOI: 10.1002/hep.27960].
  • 8Heim MH, Thimme R. Innate and adaptive immune responses inHCV infections. J Hepatol 2014; 61: S14-S25 [PMID: 25443342DOI: 10.1016/j.jhep.2014.06.035].
  • 9Thimme R, Binder M, Bartenschlager R. Failure of innate andadaptive immune responses in controlling hepatitis C virusinfection. FEMS Microbiol Rev 2012; 36: 663-683 [PMID:22142141 DOI: 10.1111/j.1574-6976.2011.00319.x].
  • 10Macaluso FS, Maida M, Minissale MG, Li Vigni T, Attardo S,Orlando E, Petta S. Metabolic factors and chronic hepatitis C: acomplex interplay. Biomed Res Int 2013; 2013: 564645 [PMID:23956991 DOI: 10.1155/2013/564645].

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部